ifosfamide has been researched along with Bone Marrow Neoplasms in 9 studies
Bone Marrow Neoplasms: Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.
Excerpt | Relevance | Reference |
---|---|---|
"The authors report a retrospective analysis of high-dose ifosfamide, carboplatin, and etoposide (HD-ICE) for patients with refractory or relapsed neuroblastoma (NB)." | 8.89 | Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature. ( Basu, EM; Cheung, NK; Kramer, K; Kushner, BH; Modak, S; Roberts, SS, 2013) |
"The authors report a retrospective analysis of high-dose ifosfamide, carboplatin, and etoposide (HD-ICE) for patients with refractory or relapsed neuroblastoma (NB)." | 4.89 | Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature. ( Basu, EM; Cheung, NK; Kramer, K; Kushner, BH; Modak, S; Roberts, SS, 2013) |
"This type of Hodgkin lymphoma is characterized by no peripheral lymphadenopathies and has been reported to have poorer prognosis." | 2.58 | Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature. ( Ito, M; Ito, R; Kageyama, Y; Katayama, N; Kawakami, K; Masuya, M; Nagaharu, K; Yamaguchi, T, 2018) |
"In patients with breast cancer, especially metastatic breast cancer, undergoing HDCT and ABMT, the presence of K19 is associated with a poor prognosis." | 1.29 | Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. ( Elfenbein, GJ; Fields, KK; Janssen, WE; Moscinski, LC; Perkins, JB; Trudeau, WL, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagaharu, K | 1 |
Masuya, M | 1 |
Kageyama, Y | 1 |
Yamaguchi, T | 1 |
Ito, R | 1 |
Kawakami, K | 1 |
Ito, M | 1 |
Katayama, N | 1 |
Landsburg, DJ | 1 |
Petrich, AM | 1 |
Abramson, JS | 1 |
Sohani, AR | 1 |
Press, O | 1 |
Cassaday, R | 1 |
Chavez, JC | 1 |
Song, K | 1 |
Zelenetz, AD | 1 |
Gandhi, M | 1 |
Shah, N | 1 |
Fenske, TS | 1 |
Jaso, J | 1 |
Medeiros, LJ | 1 |
Yang, DT | 1 |
Nabhan, C | 1 |
Kushner, BH | 2 |
Modak, S | 1 |
Kramer, K | 1 |
Basu, EM | 1 |
Roberts, SS | 1 |
Cheung, NK | 1 |
Thomson, B | 1 |
Park, JR | 1 |
Felgenhauer, J | 1 |
Meshinchi, S | 1 |
Holcenberg, J | 1 |
Geyer, JR | 1 |
Avramis, V | 1 |
Douglas, JG | 1 |
Loken, MR | 1 |
Hawkins, DS | 1 |
Yamada, K | 1 |
Sugiura, H | 1 |
Suzuki, Y | 1 |
Takahashi, M | 1 |
Fields, KK | 1 |
Elfenbein, GJ | 1 |
Trudeau, WL | 1 |
Perkins, JB | 1 |
Janssen, WE | 1 |
Moscinski, LC | 1 |
Hohaus, S | 1 |
Funk, L | 1 |
Martin, S | 1 |
Schlenk, RF | 1 |
Abdallah, A | 1 |
Hahn, U | 1 |
Egerer, G | 1 |
Goldschmidt, H | 1 |
Schneeweiss, A | 1 |
Fersis, N | 1 |
Kaul, S | 1 |
Wallwiener, D | 1 |
Bastert, G | 1 |
Haas, R | 1 |
Czyzewski, EA | 1 |
Goldman, S | 1 |
Mundt, AJ | 1 |
Nachman, J | 1 |
Rubin, C | 1 |
Hallahan, DE | 1 |
Meyers, PA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Assessment of MGMT Promoter Methylation and Clinical Benefit From Temozolomide-based Therapy in Ewing Sarcoma Patients[NCT03542097] | 82 participants (Actual) | Observational | 2014-04-15 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for ifosfamide and Bone Marrow Neoplasms
Article | Year |
---|---|
Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Brentuximab Vedotin; C | 2018 |
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carboplati | 2013 |
How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neopl | 2001 |
1 trial available for ifosfamide and Bone Marrow Neoplasms
Article | Year |
---|---|
Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteremia; Bone | 2004 |
5 other studies available for ifosfamide and Bone Marrow Neoplasms
Article | Year |
---|---|
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Ner | 2016 |
[A case of retroperitoneal neuroblastoma in an adult with extensive bone marrow metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carboplatin; Dactinomy | 2004 |
Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Marrow Transplant | 1996 |
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Breast Neoplasms; Carb | 1999 |
Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow | 1999 |